- Home
- ESPR vs BJRI Comparison
ESPR vs BJRI Comparison
Compare ESPR & BJRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESPR | BJRI |
|---|---|---|
| Founded | 2008 | 1978 |
| Country | United States | United States |
| Employees | N/A | 21000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 898.5M | 845.4M |
| IPO Year | 2013 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ESPR | BJRI |
|---|---|---|
| Price | $3.72 | $39.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $6.86 | ★ $37.67 |
| AVG Volume (30 Days) | ★ 6.5M | 475.9K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.21 |
| EPS | N/A | ★ 1.34 |
| Revenue | $303,802,000.00 | ★ $1,388,066,000.00 |
| Revenue This Year | $25.45 | $5.14 |
| Revenue Next Year | N/A | $2.66 |
| P/E Ratio | ★ N/A | $29.86 |
| Revenue Growth | 2.83 | ★ 3.85 |
| 52 Week Low | $0.69 | $28.46 |
| 52 Week High | $4.13 | $47.02 |
Technical Indicators
Market Signals| Indicator | ESPR | BJRI |
|---|---|---|
| Relative Strength Index (RSI) | 56.14 | 66.23 |
| Support Level | $3.72 | $39.33 |
| Resistance Level | $4.13 | $40.75 |
| Average True Range (ATR) | 0.24 | 1.09 |
| MACD | -0.02 | 0.15 |
| Stochastic Oscillator | 23.15 | 82.35 |
Price Performance
Historical ComparisonAbout ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About BJRI BJ's Restaurants Inc.
BJ's Restaurants Inc is involved in the business of owning and operating restaurants. The company operates in a single operating segment that is full-service company-owned restaurants. It has geographic presence only in the United States of America.